Anika Therapeutics, Inc. Deferred Income Tax Liabilities, Net
Anika Therapeutics, Inc. (ANIK) had Deferred Income Tax Liabilities, Net of $0 as of 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-03-15
- 2023-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2023-09-30: Deferred Income Tax Liabilities, Net $1.96M.
- 2023-06-30: Deferred Income Tax Liabilities, Net $3.23M.
- 2023-03-31: Deferred Income Tax Liabilities, Net $4.11M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-15 |
| 2023-09-30 | $1.96M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $3.23M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.11M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.44M 10-K · filed 2024-03-15 |
| 2022-09-30 | $6.80M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.22M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $9.96M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $10.16M 10-K · filed 2023-03-16 |
| 2021-09-30 | $12.97M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $13.10M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $10.74M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $11.89M 10-K · filed 2022-03-11 |
| 2020-09-30 | $12.58M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $14.86M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $16.03M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $4.33M 10-K/A · filed 2021-04-26 |
| 2018-12-31 | $3.54M 10-K · filed 2020-03-06 |
| 2017-12-31 | $5.39M 10-K · filed 2019-02-27 |
| 2016-12-31 | $6.55M 10-K · filed 2018-02-27 |
| 2015-12-31 | $6.78M 10-K · filed 2017-02-24 |
| 2014-12-31 | $7.74M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |